MEDICALOU: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICALOU
Largest movements
- Cash +€50,641
up €50,641 (+2,026%), from €2,500 to €53,141
mainly Net result for the year (+€35,271) and Tax, wage and social debts (+€12,461)
- Receivables within one year -€4,516
down €4,516 (-47.9%), from €9,422 to €4,907
- Tangible fixed assets +€2,145
new in 2025: €2,145
- Deferred charges and accrued income +€1,304
new in 2025: €1,304
- Profit (loss) carried forward +€35,271
up €35,271 (+467%), from €7,548 to €42,819
- Tax, wage and social debts +€12,461
up €12,461 (+665%), from €1,875 to €14,336
of which Taxes: +€9,621
- Trade debts +€1,842
new in 2025: €1,842
- Gross operating margin +€35,452
up €35,452 (+378%), from €9,374 to €44,825
- Taxes +€7,831
up €7,831 (+418%), from €1,875 to €9,705
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,922 | €61,497 | +€49,574 | +416% |
| Fixed assets | 21/28 | - | €2,145 | +€2,145 | |
| Tangible fixed assets | 22/27 | - | €2,145 | +€2,145 | |
| Plant, machinery and equipment | 23 | - | €2,145 | +€2,145 | |
| Current assets | 29/58 | €11,922 | €59,351 | +€47,429 | +398% |
| Amounts receivable within one year | 40/41 | €9,422 | €4,907 | -€4,516 | -47.9% |
| Other amounts receivable | 41 | €9,422 | €4,907 | -€4,516 | -47.9% |
| Cash at bank and in hand | 54/58 | €2,500 | €53,141 | +€50,641 | +2,026% |
| Deferred charges and accrued income | 490/1 | - | €1,304 | +€1,304 | |
| Total equity and liabilities | 10/49 | €11,922 | €61,497 | +€49,574 | +416% |
| Equity | 10/15 | €10,048 | €45,319 | +€35,271 | +351% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €7,548 | €42,819 | +€35,271 | +467% |
| Amounts payable | 17/49 | €1,875 | €16,178 | +€14,303 | +763% |
| Amounts payable within one year | 42/48 | €1,875 | €16,178 | +€14,303 | +763% |
| Trade debts | 44 | - | €1,842 | +€1,842 | |
| Suppliers | 440/4 | - | €1,842 | +€1,842 | |
| Taxes, remuneration and social security | 45 | €1,875 | €14,336 | +€12,461 | +665% |
| Taxes | 450/3 | €1,875 | €11,496 | +€9,621 | +513% |
| Remuneration and social security | 454/9 | - | €2,840 | +€2,840 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €129 | +€129 | |
| Other operating charges | 640/8 | - | €38 | +€38 | |
| Gross operating margin | 9900 | €9,374 | €44,825 | +€35,452 | +378% |
| Operating profit (loss) | 9901 | €9,374 | €44,658 | +€35,284 | +376% |
| Financial income | 75/76B | €49 | €456 | +€408 | +835% |
| Recurring financial income | 75 | €49 | €456 | +€408 | +835% |
| Financial charges | 65/66B | - | €138 | +€138 | |
| Recurring financial charges | 65 | - | €138 | +€138 | |
| Profit (loss) for the period before taxes | 9903 | €9,422 | €44,977 | +€35,554 | +377% |
| Income taxes | 67/77 | €1,875 | €9,705 | +€7,831 | +418% |
| Profit (loss) for the period | 9904 | €7,548 | €35,271 | +€27,724 | +367% |
| Profit (loss) for the period to be appropriated | 9905 | €7,548 | €35,271 | +€27,724 | +367% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.